wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33731278-17B52423-8A97-46C1-97DC-83EB826E0890
Q33731278-17B52423-8A97-46C1-97DC-83EB826E0890
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33731278-17B52423-8A97-46C1-97DC-83EB826E0890
Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
P2860
Q33731278-17B52423-8A97-46C1-97DC-83EB826E0890
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33731278-17B52423-8A97-46C1-97DC-83EB826E0890
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7680d882ce8ad11f65829c5c6b56d3388d31344a
P2860
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.